diminished maximum running speed (-10%, P < 0.05) and endurance capacity (-47%; P 37 < 0.05) that did not persist after eight weeks. In skmVEGF-/-mice gastrocnemius 38 complex time to fatigue measured in situ was 71% lower than control mice. Contraction- 
86
Although several studies have shown that skeletal muscle VEGF expression 87 increases in response to exercise (5, 19) and some studies have shown a link between 88 VEGF expression and increased capillary number in exercise trained muscle (29, 40) , 89 little attention has been given to the requirement of VEGF signaling for maintaining the 90 microvascular network in mature skeletal muscle. Tang et al. (2004) employed an AAVCre-LoxP strategy to successfully delete VEGF in all cell types within a small 92 region of adult mouse gastrocnemius muscle (37). This led to capillary regression and 93 apoptosis that persisted for at least 8 weeks in the affected area. In a similar study by 94 Kamba et al (24) , VEGF signaling was inhibited with either a small-molecule VEGFR 95 tyrosine kinase inhibitor, VEGF trap or VEGF decoy receptors and was found to lead to 96 capillary regression in some but not all adult organs. In this study, the tongue, the 97 5 skeletal muscle studied, failed to show a decrease in capillary density. Recently, our 98 laboratory reported that skeletal myofiber VEGF plays a key role in the angiogenic 99 adaptation to exercise training, but capillaries in non-exercised, VEGF-deficient muscle 100 did not regress (13).
101
In skeletal muscle, the myofiber is a major source of VEGF expression (21). 
184
For each test, the muscle was mounted in a chamber that was continuously perfused with was measured by recording force output at stimulation frequencies of 1, 15, 30, 50, 80, 196 100, and 120 Hz (500 ms train duration, 0.2 ms pulse duration) for soleus and 1, 10, 15, 197 30, 45, 60, 75, 90, 120, 150 Hz (300 ms train duration, 0.2 ms pulse duration) for EDL.
198
The muscles were stimulated to contract once every 2 minutes to prevent fatigue.
199
Stability of the muscle was checked by periodically stimulating the muscle at maximal respectively, lower in skmVEGF-/-mice than the control, VEGF+/+ group ( Figure 1A ).
272
Similarly, on day 58 post-tamoxifen, VEGF levels were reduced by 92 and 97% in the 273 gastrocnemius and soleus, respectively ( Figure 1B) . VEGF protein levels in skmVEGF-274 11 /-EDL were below detection levels in some samples ( Figure 1B) . VEGF+/+ and pre-275 mutant skmVEGF-/-mice that were not given tamoxifen showed no reduction in skeletal 276 muscle VEGF protein levels (see Supplement Figure S1 ). VEGF levels in the heart, lung, 277 kidney and brain from skmVEGF-/-mice were normal (Figure 2) .
278
Exercise limitation. On day 21 post-tamoxifen administration the maximum running 279 speed of skmVEGF-/-mice was 10% (P < 0.05) lower than the control group (Figure 3) . 
285
Body mass and muscle size. Body weights were not different between VEGF+/+ and 286 skmVEGF-/-groups before tamoxifen (see Supplement Table S1 ) or at 21 and 56 days 287 post-tamoxifen (Table 1) . Muscle mass and cross-sectional areas of the gastrocnemius, 288 soleus and EDL in the skmVEGF-/-mice were also not different than the control group 289 (Table 1) . conformation that myofiber-expressed VEGF is not necessary to maintain the capillary 323 bed (at least over the 8 week time period studied in these mice); 3) that whole body 324 exercise performance was acutely impaired in skeletal myofiber VEGF-deficient mice. pericytes, macrophages, and fibroblasts (6, 7, 12, 17, 25) . For instance, endothelial cell 347 targeted VEGF deletion has been reported to result in endothelial apoptosis and unstable gastrocnemius, n=5-6 for soleus and n=3-6 for EDL. * indicates a significant difference 598 compared to VEGF+/+ mice (P<0.001).
599
Figure 2. Post-tamoxifen VEGF protein levels in heart, lung, kidney and brain. As expected, 600 there were no differences in VEGF levels between the two groups in heart, lung, kidney or brain.
601
Mean ± SE, n=6. 
